EORTC-24863-HNCG

Phase II Randomized Chemotherapy Trial of CHIP vs CACP in Patients with Advanced Ovarian Cancer Refractory or Recurrent After First-Line Chemotherapy with CBDCA (Summary Last Modified 05/88
Trial StatusAll trial activities ended
DatesDate of activation: 15-Oct-86
Closed on : 15-Nov-87
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size14
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT